Status:

RECRUITING

Vanderbilt Memory and Aging Project

Lead Sponsor:

Vanderbilt University Medical Center

Collaborating Sponsors:

National Institute on Aging (NIA)

National Institute of Neurological Disorders and Stroke (NINDS)

Conditions:

Alzheimer Disease

Aging

Eligibility:

All Genders

60+ years

Brief Summary

This study will use an observational cohort to cross-sectionally and longitudinally relate vascular health to clinical, imaging, and biological markers of early Alzheimer's disease and cerebrovascular...

Detailed Description

As the population ages, Alzheimer's disease and dementia are becoming a public health crisis. In the initial cycle, the Vanderbilt Memory \& Aging Project was established to examine cardiovascular fun...

Eligibility Criteria

Inclusion

  • Participants recruited will include 1,000 adults age 50 and older.
  • After the eligibility visit, a small portion of participants (\~150) enrolling must meet diagnostic criteria for mild cognitive impairment according to a clinician diagnosis and/or medical records (i.e., participants must have mild memory or cognitive problems, but they must be free of any functional problems and not have Alzheimer's disease or another form of dementia). The remaining \~850 participants will be cognitively unimpaired adults age 50 and older.
  • Because the neuropsychological tests used to measure cognitive performance are validated on English-speaking populations, we require that English be the primary language of all participants.

Exclusion

  • No available reliable study partner
  • History of major psychiatric illness (e.g., schizophrenia, bipolar), neurological illness (e.g., stroke, epilepsy, multiple sclerosis, Parkinson's disease, dementia), or head injury with significant loss of consciousness. These exclusion criteria have been applied because they affect brain structure and function.
  • Diagnosis of congestive heart failure
  • Diagnosis of atrial fibrillation or other heart arrhythmia
  • Diagnosis of Chronic obstructive pulmonary disease
  • Diagnosis of cancer (current)
  • History of serious alcohol or drug abuse (past or current)
  • Participants unable to undergo MRI will be excluded. Reasons may include: a. Subjects who have any type of bioimplant activated by mechanical, electronic, or magnetic means (e.g., cochlear implants, pacemakers, neurostimulators, biostimulators, electronic infusion pumps, etc.). b. Subjects who have any type of ferromagnetic bioimplant that could potentially be displaced. c. Subjects who have cerebral aneurysm clips. d. Subjects who may have shrapnel imbedded in their bodies (e.g., from war wounds), metal workers and machinists (e.g., potential for metallic fragments in or near the eyes). e. Subjects who are pregnant. Given that the minimum age of recruitment for the current study is 50 years of age, it is unlikely that prospective participants will be excluded because of pregnancy. f. Subjects who have excessive amounts of metal dental work based on records released by their dentist.

Key Trial Info

Start Date :

September 17 2012

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2026

Estimated Enrollment :

1000 Patients enrolled

Trial Details

Trial ID

NCT05372159

Start Date

September 17 2012

End Date

December 31 2026

Last Update

August 6 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Vanderbilt University Medical Center

Nashville, Tennessee, United States, 37232